Target intelligence / Profile preview

Alpha-neurotoxin (Bungarus caeruleus) (α-NTX)

Target
α-NTX
Molecular classification
Three-finger toxin (3FTx) family, Alpha-neurotoxin subfamily, Protein
01

Overview

Common Krait long-chain three-finger alpha-neurotoxins are a class of potent neurotoxic proteins found in the venom of the snake Bungarus caeruleus [PubMed: 30219148]. These toxins belong to the three-finger toxin (3FTx) superfamily, characterized by a structural motif of three beta-stranded loops extending from a central core [UniProt: Family: Three-finger toxin family]. Their primary biological function is to act as high-affinity antagonists of the nicotinic acetylcholine receptors (nAChRs) located at the postsynaptic membrane of the neuromuscular junction [PubMed: 15649515]. By binding to these receptors, the toxins prevent the neurotransmitter acetylcholine from initiating muscle contraction, leading to progressive flaccid paralysis [WHO: Snakebite envenoming]. In clinical cases of envenomation, this paralysis often results in fatal respiratory failure if not treated promptly with appropriate antivenom [PubMed: 25463111]. These toxins are the primary targets for neutralization by polyvalent and monovalent antivenoms, which contain antibodies that bind and sequester the toxins [StatPearls: Snake Toxicity]. Additionally, they are widely used in pharmacological research as molecular probes to study the structure and function of acetylcholine receptors [PubMed: 11744018].

Other names
Long-chain three-finger alpha-neurotoxinCommon Krait alpha-neurotoxinPostsynaptic neurotoxin3FTxBungarotoxin
02

Mechanism of action

Neutralization of the toxin by antibody binding, which prevents the toxin from interacting with nicotinic acetylcholine receptors at the neuromuscular junction.

03

Biological functions

Nicotinic acetylcholine receptor bindingInhibition of neuromuscular transmissionNeurotoxicity
04

Disease associations

Snakebite envenomationNeuromuscular paralysisRespiratory failure
05

Safety considerations

Lethal respiratory failureRapid onset of actionPotential for irreversible binding to receptorsRisk of anaphylaxis from antivenom treatment
06

Interacting drugs

Common Krait Antivenom

2 more in the full profile.

07

Biomarkers

Venom antigen levels (ELISA)Clinical signs of neurotoxicity (e.g., ptosis)Respiratory rate and capacity

Beyond the preview

Go deeper on Alpha-neurotoxin (Bungarus caeruleus) (α-NTX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-neurotoxin (Bungarus caeruleus) (α-NTX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call